For most adults with newly diagnosed type 2 diabetes without cardiorenal disease, metformin plus lifestyle modification remains initial therapy, with GLP-1 agonists as preferred second-line agents
That doesn't automatically mean the practice is unsafe or ineffective, but it does mean you're venturing beyond what has been formally studied and approved
For further clinical guidance on how to manage your patients that are affected by the shortage, you can refer to this tailored guidance produced by the Primary Care Diabetes Society (PCDS) and Association of British Clinical Diabetologists (ABCD): Guidance Document If you would also like to view the original alert, please click here.
PRECAUTION: Avoid breathing dust/fume/gas/mist/vapours/spray
When her schedule gets full, she finds opportunities to work in some exercise
5 Clinical studies have demonstrated that patients with Systemic Lupus Erythematosus (SLE), an autoimmune condition, exhibit lower levels of Dipeptidyl peptidase-4 (DPP4) in their serum and peripheral blood mononuclear cells compared to healthy individuals